Bevacizumab-resistant tumor cell-derived FGFBP1 induced fibroblast activation protein α expression by enhancing the paracrine FGF2/FGFR1/ERK1/-2/EGR1 signaling pathway in hepatic stellate cells 27. Here, FGF2 is linked to neoplasm.